Noninvasive Detection of Neuroendocrine Prostate Cancer through Targeted Cell-free DNA Methylation.

Franceschini GM, Quaini O, Mizuno K, Orlando F, Ciani Y, Ku SY, Sigouros M, Rothmann E, Alonso A, Benelli M, Nardella C, Auh J, Freeman D, Hanratty B, Adil M, Elemento O, Tagawa ST, Feng FY, Caffo O, Buttigliero C, Basso U, Nelson PS, Corey E, Haffner MC, Attard G, Aparicio A, Demichelis F, Beltran H

Open source

DOI: 10.1158/2159-8290.cd-23-0754
Published: 2024 Mar 1
Container: Cancer discovery
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/2159-8290.cd-23-0754,
  title = {Noninvasive Detection of Neuroendocrine Prostate Cancer through Targeted Cell-free DNA Methylation.},
  author = {Franceschini GM and Quaini O and Mizuno K and Orlando F and Ciani Y and Ku SY and Sigouros M and Rothmann E and Alonso A and Benelli M and Nardella C and Auh J and Freeman D and Hanratty B and Adil M and Elemento O and Tagawa ST and Feng FY and Caffo O and Buttigliero C and Basso U and Nelson PS and Corey E and Haffner MC and Attard G and Aparicio A and Demichelis F and Beltran H},
  year = {2024},
  journal = {Cancer discovery},
  doi = {10.1158/2159-8290.cd-23-0754},
  url = {https://doi.org/10.1158/2159-8290.cd-23-0754}
}

RIS

TY  - JOUR
TI  - Noninvasive Detection of Neuroendocrine Prostate Cancer through Targeted Cell-free DNA Methylation.
AU  - Franceschini GM
AU  - Quaini O
AU  - Mizuno K
AU  - Orlando F
AU  - Ciani Y
AU  - Ku SY
AU  - Sigouros M
AU  - Rothmann E
AU  - Alonso A
AU  - Benelli M
AU  - Nardella C
AU  - Auh J
AU  - Freeman D
AU  - Hanratty B
AU  - Adil M
AU  - Elemento O
AU  - Tagawa ST
AU  - Feng FY
AU  - Caffo O
AU  - Buttigliero C
AU  - Basso U
AU  - Nelson PS
AU  - Corey E
AU  - Haffner MC
AU  - Attard G
AU  - Aparicio A
AU  - Demichelis F
AU  - Beltran H
PY  - 2024
JO  - Cancer discovery
DO  - 10.1158/2159-8290.cd-23-0754
UR  - https://doi.org/10.1158/2159-8290.cd-23-0754
ER  -

APA

GM, F., O, Q., K, M., F, O., Y, C., SY, K., M, S., E, R., A, A., M, B., C, N., J, A., D, F., B, H., M, A., O, E., ST, T., FY, F., O, C., C, B., U, B., PS, N., E, C., MC, H., G, A., A, A., F, D., & H, B. (2024). Noninvasive Detection of Neuroendocrine Prostate Cancer through Targeted Cell-free DNA Methylation.. Cancer discovery. https://doi.org/10.1158/2159-8290.cd-23-0754

Source records

pubmed · retrieved 2026-09-26T10:29:57.088Z
europe-pmc · retrieved 2026-09-26T10:29:57.110Z